Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?
A side-by-side comparison of the two leading weight loss medications — how they work differently, clinical results, side effects, and how to choose.
Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?
If you are considering a GLP-1 medication for weight loss, you have likely encountered two names: semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). Both produce significant weight loss — but they work differently, and one may be better suited to your situation.
How They Differ
Semaglutide: Single Receptor
Semaglutide is a GLP-1 receptor agonist. It activates one receptor — GLP-1 — which reduces appetite, slows gastric emptying, and improves insulin sensitivity.
Tirzepatide: Dual Receptor
Tirzepatide activates two receptors — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism is sometimes called a "twincretin." The GIP component adds:
- Enhanced insulin sensitivity beyond GLP-1 alone
- Improved fat metabolism and energy expenditure
- Potentially greater appetite suppression through complementary pathways
Think of it this way: semaglutide presses one button. Tirzepatide presses two.
Clinical Trial Comparison
| Metric | Semaglutide (STEP trials) | Tirzepatide (SURMOUNT trials) |
|---|---|---|
| Average weight loss | 15–17% | 20–26% |
| Patients losing >20% | ~30% | ~50–60% |
| A1c reduction | 1.5–1.8% | 2.0–2.4% |
| Trial duration | 68 weeks | 72 weeks |
| Dosing | Weekly injection | Weekly injection |
The SURMOUNT-1 trial showed tirzepatide at the highest dose (15mg) produced an average weight loss of 22.5% — approximately 52 pounds for a 230-pound person.
Side Effect Profile
Both medications share similar gastrointestinal side effects, particularly during dose escalation:
| Side Effect | Semaglutide | Tirzepatide |
|---|---|---|
| Nausea | ~44% | ~30% |
| Diarrhea | ~30% | ~23% |
| Constipation | ~24% | ~16% |
| Vomiting | ~24% | ~13% |
Tirzepatide appears to have a milder side effect profile in clinical data, with lower rates of nausea and vomiting. Some providers attribute this to the GIP receptor activation, which may buffer against GLP-1-related nausea.
Both medications' side effects are dose-dependent and typically improve with slow titration.
How to Choose
Semaglutide May Be Better If:
- You have less weight to lose (15–40 pounds)
- You want the medication with the longest track record (more years of real-world data)
- Cost is a primary concern — compounded semaglutide is generally less expensive
- You responded well to semaglutide previously
- You have primarily appetite-driven weight gain
Tirzepatide May Be Better If:
- You have significant weight to lose (50+ pounds)
- You have type 2 diabetes or insulin resistance (the dual mechanism is particularly effective here)
- You tried semaglutide and plateaued
- You experienced significant GI side effects on semaglutide
- You want maximum weight loss potential
Either Is a Good Choice If:
- Your BMI is 30+ (or 27+ with comorbidities)
- Diet and exercise alone have not produced lasting results
- You are committed to lifestyle modifications alongside medication
- You have no contraindications
The Combination Approach
For women going through menopause, combining a GLP-1 medication with hormone replacement therapy addresses weight gain from multiple angles — hormonal optimization plus metabolic support. For men, combining with TRT can help preserve muscle mass during weight loss.
Switching Between Medications
If you start one and it is not working well, switching to the other is possible. Common reasons to switch:
- Intolerable side effects on one but not the other
- Weight loss plateau after initial success
- Better insurance coverage for one medication
- Desire for the dual-receptor mechanism of tirzepatide
Your provider will manage the transition, typically starting the new medication at a low dose after a washout period.
Cost Comparison
| Brand Semaglutide | Compounded Semaglutide | Brand Tirzepatide | Compounded Tirzepatide | |
|---|---|---|---|---|
| Monthly cost | $1,000–1,600 | ~$349 | $1,000–1,100 | ~$399 |
| Insurance | Varies | N/A | Varies | N/A |
| Labs included | No | Yes (YouthFuel) | No | Yes (YouthFuel) |
Use our Cost Calculator to see your specific savings potential.
Bottom Line
Both semaglutide and tirzepatide are effective, well-studied weight loss medications. Tirzepatide shows modestly better results in clinical trials, but semaglutide has a longer track record and lower cost. The "best" medication is the one your provider recommends based on your specific health profile, goals, and tolerance.
Take our free health assessment to find out which option makes sense for you.
Explore our semaglutide protocol or tirzepatide protocol.